trump medicare glp 1 will pay $245 per month for GLP-1 drugs, while qualifying recipients only have to pay $50 per month The Trump administration is preparing

doi: 10.1093/ajcn/78.2.250

Because sermorelin lacks a current NDA sponsor, no PREA-compliant pediatric data package exists, leaving clinicians reliant on the 1990 Walker trial, smaller case series, and adult extrapolations from studies of GHRH analogs such as tesamorelin

Potential Risks and Considerations While BPC-157 shows enormous promise for gut healing, its important to understand the potential risksespecially since its not an FDA-approved treatment and lacks large-scale human trials

Beyond inducing weight loss, these treatments have demonstrated benefits on obesity-related complications, including neuropsychiatric and substance use disorders, peripheral vascular disease, arthritis, MASLD, hypertension and renal disorders, positioning them as a central focus in current obesity research [3]

doi: 10.1136/bmj.c5702 62

This is optimal